Brain NAD in Alzheimer's Disease (NCT07127510)
Measurement of Brain NAD Levels in Alzheimer's Patients and Control Subjects by 1H-MRS
🩺 Plain-English Summary (8th-Grade Level)
The goal of this observational study is to learn about the levels of nicotinamide adenine dinucleotide (NAD) in the brains of people with Alzheimer's disease. The study aims to determine if brain NAD levels are lower in people with Alzheimer's disease compared with people of the same age group who do not have Alzheimer's disease. Participants with or without Alzheimer's disease will have a brain imaging session where NAD will be measured using magnetic resonance spectroscopy (MRS). Eight months later, they will have a second, similar, brain imaging session.
Who can join: Review the eligibility criteria below.
Location: FAU Clinical Research Unit — Boca Raton, Florida
Age range: 65 Years to 80 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- FAU Clinical Research Unit — Boca Raton, Florida
📞 Contact the Study Coordinator
Phone: (561) 235-4467
Email: CRUDOR@health.fau.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer Disease (AD)
- Arlington Longitudinal Optimal Healthy Aging Study (ALOHA) — Arlington, Virginia
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease — Boston, Massachusetts
- Daridorexant for Alzheimer Disease Prevention — Montreal, Quebec
Explore by condition: All Alzheimer Disease (AD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.